Products and services

FILE - In this Oct. 14, 2020, file photo, a man wearing a face mask to protect against the coronavirus walks past a billboard advertising Chinese technology firm Huawei at the PT Expo in Beijing. Chinese tech giant Huawei, one of the biggest makers of smartphones and switching equipment, said Friday, Oct. 23, 2020 its revenue rose 9.9% in the first nine months of this year, but growth slowed due to U.S. sanctions and the coronavirus pandemic. (AP Photo/Mark Schiefelbein, File)
October 23, 2020 - 2:07 am
BEIJING (AP) — Chinese tech giant Huawei, one of the biggest makers of smartphones and switching equipment, said Friday its revenue rose 9.9% in the first nine months of this year, but growth decelerated in the face of U.S. sanctions and the coronavirus pandemic. Huawei Technologies Ltd. gave no...
Read More
The new Huawei Mate 40 Pro smartphone is held for a photo, in London, Wednesday Oct. 21, 2020. Huawei, has unveiled its Mate 40 line of phones, Thursday Oct. 22, 2020, a product release that comes at a crucial moment for the company. (AP Photo/James Brooks)
October 22, 2020 - 8:02 am
LONDON (AP) — Huawei’s new smartphone has an upgraded camera, its latest advanced chipset and a better battery. What it may not have outside the Chinese tech giant’s home market is very many buyers. Huawei, which recently became the world’s No. 1 smartphone maker, on Thursday unveiled its Mate 40...
Read More
FILE - In this Sept. 10, 2019 file photo, Jack Ma, founder of the Alibaba Group, speaks at the company's 20th-anniversary celebration in Hangzhou in eastern China's Zhejiang province. A survey shows Jack Ma, founder of e-commerce giant Alibaba, held onto his status as China's richest entrepreneur as the coronavirus shutdown propelled demand for online shopping and other services. (Chinatopix via AP, File)
October 20, 2020 - 12:42 am
BEIJING (AP) — Jack Ma, founder of e-commerce giant Alibaba, held onto his status as China’s richest tycoon this year as surging demand for online shopping and other services during the coronavirus pandemic swelled the fortunes of internet entrepreneurs, according to a survey released Tuesday. Ma’s...
Read More
FILE - This Dec. 11, 2019 file photo shows Channing Dungey at The Hollywood Reporter's Women in Entertainment Breakfast Gala in Los Angeles. Dungey has been named chairman, Warner Bros. Television Group, starting her tenure at the studio early next year. The news was announced today by Ann Sarnoff, Chair and CEO, WarnerMedia Studios and Networks Group, to whom she will report. Dungey will succeed Peter Roth who will be stepping down from his Studio responsibilities running the TV Group and its operating divisions in early 2021. (Photo by Jordan Strauss/Invision/AP, File)
October 19, 2020 - 12:56 pm
LOS ANGELES (AP) — Veteran TV industry executive Channing Dungey was named chairman of the Warner Bros. Television Group after tenures at ABC and Netflix in which she shepherded hit series including “Scandal." Dungey, who at ABC in 2016 became the first African American head of a network...
Read More
October 16, 2020 - 3:13 pm
DALLAS (AP) — The staff of the Dallas Morning News voted to unionize Friday, becoming the first newspaper in Texas to do so amid a recent wave of labor organizing at news outlets across the country. The Dallas News Guild announced that employees of the paper and its Spanish-language sister...
Read More
FILE - In this July 17, 2020 file photo, a senior citizen holds the hand of a care coordinator at a Health facility in Miami. Federal health officials on Friday unveiled a plan to get approved coronavirus vaccines to nursing home residents free of cost, with the aid of two national pharmacy chains. No vaccine has yet been approved by the Food and Drug Administration, and the distribution program is contingent on that happening first. (AP Photo/Wilfredo Lee)
Associated Press
October 16, 2020 - 9:24 am
WASHINGTON (AP) — Federal health officials on Friday unveiled a plan to get approved coronavirus vaccines to nursing home residents free of cost, with the aid of two national pharmacy chains. No vaccine has yet been approved by the Food and Drug Administration, and the distribution program is...
Read More
In this Sept. 24, 2020, file photo, an employee manually inspects syringes of the SARS CoV-2 Vaccine for COVID-19 produced by Sinovac at its factory in Beijing. China is rapidly increasing the number of people receiving its experimental coronavirus vaccines, with a city offering one to the general public and a biotech company providing another free to students going abroad. (AP Photo/Ng Han Guan, File)
October 16, 2020 - 3:50 am
TAIPEI, Taiwan (AP) — China is rapidly increasing the number of people receiving its experimental coronavirus vaccines, with a city offering one to the general public and a biotech company providing another free to students going abroad. The city of Jiaxing, south of Shanghai, is offering a vaccine...
Read More
People walk past a Miniso shop at a shopping mall in Beijing, Thursday, Oct. 15, 2020. Miniso, a Chinese discount retailer known for its fashionable but affordable household products, is expected to raise up to $562 million in a U.S. initial public offering in New York. The Guangzhou-based retailer is the latest Chinese company to list in the U.S., amid tensions that have taken U.S.-China relations to their worst level in decades. (AP Photo/Mark Schiefelbein)
October 15, 2020 - 10:22 am
HONG KONG (AP) — Shares of Miniso Group Holding jumped in their first day of trading, while the broader markets were on pace for their third straight loss this week. Miniso, a Chinese discount retailer known for its fashionable but affordable household products, raised $608 million in a U.S...
Read More
This image provided by Regeneron on Wednesday, Oct. 14, 2020, shows a vial of the company's Inmazeb medication. On Wednesday, the U.S. Food and Drug Administration said it has approved the drug for treating Ebola in both adults and children. (Regeneron via AP)
October 14, 2020 - 5:44 pm
U.S. regulators Wednesday approved the first drug for the treatment of Ebola. The Food and Drug Administration OK'd the drug developed by Regeneron Pharmaceuticals for treating adults and children with the Zaire Ebola virus strain, the most deadly of six known types. It typically kills 60% to 90%...
Read More
FILE - In this May 2020 photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. (David Morrison/Eli Lilly via AP)
October 13, 2020 - 1:36 pm
Independent monitors have paused enrollment in a study testing the COVID-19 antiviral drug remdesivir plus an experimental antibody therapy being developed by Eli Lilly that’s similar to a treatment President Donald Trump recently received. Lilly confirmed Tuesday that the study had been paused “...
Read More

Pages